# Solace Stress Urinary inContinence Control Efficacy and Safety Study

> **NCT02210273** · NA · COMPLETED · sponsor: **Solace Therapeutics, Inc.** · enrollment: 221 (actual)

## Conditions studied

- Stress Urinary Incontinence

## Interventions

- **DEVICE:** Solace Bladder Control (Vesair) Balloon
- **DEVICE:** Solace Sham Treatment

## Key facts

- **NCT ID:** NCT02210273
- **Lead sponsor:** Solace Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-11
- **Primary completion:** 2015-12-18
- **Final completion:** 2019-03-30
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2019-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02210273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02210273, "Solace Stress Urinary inContinence Control Efficacy and Safety Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02210273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*